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ABSTRACT
Purpose: Perineural invasion (PNI) on needle prostatic biopsies (NPB) has been controversial as a marker of extraprostatic 
extension and consequently for planning of nerve-sparing radical prostatectomy (RP). The aim of this study was to find 
whether tumor extent on NPB influences the value of PNI to predict stage > pT2 on RP.
Materials and Methods: This retrospective study was based on 264 consecutive patients submitted to radical retropubic 
prostatectomy. Their NPB were matched with whole-mount processed and totally embedded surgical specimens. Tumor 
extent on NPB was evaluated as the percentage of linear tissue in mm containing carcinoma in all cores. Considering the 
median value, patients were stratified into 2 groups: harboring less or more extensive tumors on NPB. Univariate and multi-
variate logistic regression analyses were used to relate stage > pT2 to PNI and other clinical and pathological variables.
Results: In patients with more extensive tumors, PNI was predictive of stage > pT2 in univariate analysis but not in multi-
variate analysis. In less extensive tumors, PNI showed no association between any clinical or pathological variables studied; 
no difference in the time to biochemical progression-free status compared to patients without PNI; and, no predictive value 
for pathological stage > pT2 on both univariate and multivariate analyses.
Conclusion: Tumor extent on NPB influences the predictive value of PNI for pathologic stage > pT2 on RP. With a higher 
number of small tumors currently detected, there is no evidence that perineural invasion should influence the decision on 
preservation of the nerve during radical prostatectomy.
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INTRODUCTION
 Perineural invasion (PNI) on needle pros-
tatic biopsies as a marker of extraprostatic extension 
has been controversial (1-15). In almost all studies, 
perineural invasion has been related to extraprostatic 
extension in univariate analysis but in only a few 
 Clinical Urology 
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studies in multivariate analysis. The practical impor-
tance relates to the decision of whether to sacrifice 
part or all of the neurovascular bundle on the side 
of the biopsy with PNI when planning nerve-sparing 
radical prostatectomy. The aim of this study was to 
determine whether tumor extent on needle biopsies 
significantly influences the value of PNI to predict 
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stage > pT2 (pT3a and/or pT3b) on radical prosta-
tectomies.
MATERIALS AND METHODS
 This retrospective study was based on 264 
consecutive patients submitted to radical retropubic 
prostatectomy by one surgeon (UF) in the period 
1997 to 2008 due to clinically localized (T1c or T2) 
prostate adenocarcinoma. Their needle prostatic bi-
opsies (mean 9 cores per biopsy) were matched with 
whole-mount processed and totally embedded surgi-
cal specimens. A mean of 32 paraffin blocks were 
processed, and 6μm sections from each block were 
stained with hematoxylin and eosin. PNI was consid-
ered as prostate cancer extension along the perineural 
sheath (Figure-1). The presence of any PNI, regardless 
of amount, was recorded as positive for PNI. Positive 
surgical margins were defined as cancer cells touch-
ing the inked surface of the prostate. Extraprostatic 
extension (pT3a) was diagnosed whenever cancer was 
seen in adipose tissue and, in case of desmoplastic 
response, whenever a protuberance corresponding 
to extension of tumor into the periprostatic tissue 
was seen (16). Seminal vesicle invasion (pT3b) was 
defined as invasion of the muscular wall (17).
 Extent on needle biopsy was evaluated as the 
percentage of linear tissue in mm containing carcinoma. 
Considering the median value of extent, biopsies were 
stratified into 2 equal groups: 132 biopsies with less 
extensive and 132 biopsies with more extensive tumors. 
Tumor extent on radical prostatectomy was estimated 
by use of a point-count method previously described 
(18,19). Grading was according to the standard Gleason 
system (20,21). All pathological findings were evalu-
ated by one senior uropathologist (AB).
 Clinical variables analyzed included preop-
erative serum prostate-specific antigen (PSA), age 
and clinical stage (T1c or T2). Total serum PSA was 
measured utilizing previous validated Immulite® PSA 
kit. Biochemical progression was defined as PSA ≥ 0.2 
ng/mL according to recommendation of the American 
Urological Association (22). After radical prostatec-
tomy, serum PSA was drawn every 3 months during 
the first year, every 6 months during the second year, 
and annually thereafter. The mean and median follow-
up of the patients was 28 and 20 months, respectively. 
No patient of this series was treated before or after 
surgery.
 The data were analyzed using the Mann-
Whitney test for comparison of means and the Fishers 
exact test for comparison of proportions. Time to bio-
chemical (PSA) progression-free outcome was studied 
using the Kaplan-Meier product-limit analysis; the 
comparison between the groups was done using the 
Log-rank test. Univariate and multivariate analyses 
using a logistic regression model was used to relate 
the outcomes of prostatectomy stage > pT2 to several 
clinical and pathological variables. Two-sided P value 
< 0.05 was considered statistically significant. All 
statistical analyses were performed using the com-
mercially available SPSS 15.0.
RESULTS
 Table-1 shows the clinical and pathological 
findings of the 264 patients studied. Perineural inva-
sion was present in 48/264 (18.2%) biopsies. The 
median value of tumor extent on biopsy was 13.6%. 
The frequency of PNI in the group with less extent tu-
mors (≤ 13.6% of tissue in mm containing carcinoma) 
was 10.6%; in the group with more extensive tumors 
(> 13.6% of tissue in mm containing carcinoma) the 
frequency of PNI was 25.8%.
Figure 1 – Perineural invasion on needle prostatic biopsy (HE, 
X400).
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SD = standard deviation.
 Table-2 shows the association of PNI to 
several clinical and pathological variables compar-
ing patients with less extensive and more extensive 
tumors. On biopsies showing more extensive tumors 
and PNI, patients showed statistically significant 
higher Gleason score on biopsy (p = 0.02), more ex-
traprostatic extension (p = 0.02), and more seminal 
vesicle invasion (p = 0.04). On biopsies showing less 
extensive tumors and PNI, there was no statistical 
significant association to all variables studied.
 Figures-2 and 3 show the Kaplan-Meier bio-
chemical progression-free survival curve following 
radical prostatectomy. In patients with less extensive 
tumors on biopsy (Figure-2), at 5 years, 71% of 
the patients without PNI were free of biochemical 
progression compared to 83% of the patients with 
PNI. There was no statistically significant difference 
between the groups (log-rank, p = 0.24). In patients 
with more extensive tumors on biopsy (Figure-3), at 
5 years, 43% of the patients without PNI were free of 
biochemical progression compared to 33% of the pa-
tients with PNI. There was no statistically significant 
difference between the groups (Log-rank, p = 0.26).
 Table-3 shows the univariate and multivariate 
logistic regression analyses of several clinical and 
pathological variables predictive of pathological 
stage > T2 on radical prostatectomy in patients with 
less extensive tumors on biopsy. PNI was not predic-
tive of stage > pT2 on both analyses. On univariate 
analysis, only extent of cancer and Gleason score 
on biopsy were predictive. On multivariate analysis, 
extent of tumor on biopsy was statistically significant 
and Gleason score on the level of significance.
 Table-4 shows the univariate and multivariate 
logistic regression analyses of several clinical and 
pathological variables predictive of pathological stage 
> T2 on radical prostatectomy in patients with more 
extensive tumors on biopsy. PNI was predictive of 
stage > pT2 only on univariate analysis. Other vari-
ables statistically significant on univariate analysis 
were preoperative PSA, tumor extent on needle bi-
opsy, and Gleason score on biopsy. On multivariate 
analysis, only extent of tumor on needle biopsy was 
an independent predictor of stage > pT2 (pT3a and/or 
pT3b) on radical prostatectomy.
COMMENTS
 Our study showed that extent of tumor influ-
ences the value of PNI to predict pathological stage 
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Figure 2 – Kaplan-Meier biochemical (PSA) progression-free survival curve of patients with and without PNI on 132 biopsies with ≤ 
13.6% of tissue in mm containing carcinoma (log-rank, p = 0.24).
Figure 3 – Kaplan-Meier biochemical (PSA) progression-free survival curve of patients with and without PNI on 132 biopsies with > 
13.6% of tissue in mm containing carcinoma (Log-rank, p = 0.26).
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Table 2 – Association of perineural invasion (PNI) to several clinical and pathological variables on 132 biopsies with less 
extensive tumors (≤ 13.6% of tissue in mm containing carcinoma) and 132 biopsies with more extensive tumors (> 13.6% 
of tissue in mm containing carcinoma).
Variable PNI in Biopsies with Less 
Extensive Tumors
p Value




Clinical stage 0.47(2) 0.66(2)
Preoperative PSA 0.36(1) 0.14(1)
Gleason score on needle biopsy 0.79(1) 0.02(1)
Tumor extent on radical prostatectomy 0.13(1) 0.09(1)
Positive margins 0.23(2) 0.16(2)
Extraprostatic extension 0.43(2) 0.02(2)
Seminal vesicle invasion 0.24(2) 0.04(2)
(1) Mann-Whitney test; (2) Fisher’s exact test
Table 3 – Univariate and multivariate logistic regression analyses of several clinical and pathological variables predictive 
of pathological stage > pT2 (pT3a/pT3b) on 132 biopsies with  less extensive tumors (≤ 13.6% of tissue in mm containing 
carcinoma).
Clinical and Pathological 
Variables




p Value Hazard ratio
(95% CI)
p Value
Age 1.02 (0.95-1.10) 0.63 1.01 (0.93-1.09) 0.86
Clinical stage 0.59 (0.22-1.60) 0.30 0.51 (0.16-1.58) 0.24
Preoperative PSA 1.04 (0.95-1.13) 0.46 1.04 (0.93-1.17) 0.46
Extent of cancer on biopsy 1.24 (1.09-1.41) < 0.01 1.22 (1.05-1.42) 0.01
Gleason score on biopsy 2.82 (1.27-6.26) 0.01 2.43 (1.01-5.85) 0.05
PNI on biopsy 1.52 (0.38-5.97) 0.55 1.23 (0.28-5.29) 0.78
CI = confidence interval; PNI = perineural invasion.
> T2 on radical prostatectomies. In patients with less 
extensive tumors on biopsy (≤ 13.6% of tissue in 
mm containing carcinoma) and PNI, there was no 
association to any one clinical or pathological vari-
able studied; no difference in the time to biochemical 
(PSA) progression-free outcome compared to patients 
without PNI; and, no predictive value for pathological 
stage > pT2 on both univariate and multivariate analy-
sis. The only study to mention the influence of extent 
of tumor to the predictive value of PNI is Rubins’s 
et al. (6). In their study, PNI revealed a significant 
association with stage pT3 on univariate analysis. 
However, on multivariate analysis the association 
was significant only when the greatest percentage of 
any single biopsy involved by prostate carcinoma and 
the total percentage of cancer in all cores were not 
considered, due to a significant interaction between 
these measures and PNI.
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Table 4 – Univariate and multivariate logistic regression analyses of several clinical and pathological variables predic-
tive of pathological stage > pT2 (pT3a/pT3b) on 132 biopsies with  more extensive tumors (> 13.6% of tissue in mm 
containing carcinoma).
Clinical and Pathological 
Variables
Univariate Analysis Multivariate Analysis
Hazard ratio
(95% CI)
p Value Hazard ratio
(95% CI)
p Value
Age 1.02 (0.97-1.08) 0.41 1.01 (0.94-1.07) 1.00
Clinical stage 1.48 (0.68-3.20) 0.32 0.88 (0.36-2.20) 0.79
Preoperative PSA 1.09 (1.03-1.15) 0.01 1.07 (1.00-1.08) 0.06
Extent of cancer on biopsy 1.06 (1.03-1.08) < 0.01 1.05 (1.03-1.08) < 0.01
Gleason score on biopsy 1.92 (1.13-3.30) 0.02 1.47 (0.79-2.73) 0.22
PNI on biopsy 3.32 (1.48-3.33) < 0.01 1.67 (0.64-4.37) 0.30
CI = confidence interval; PNI = perineural invasion.
 The findings with more extensive tumors on 
biopsy are in accordance with most of the studies 
in the literature. Egan and Bostwick (2) found on 
univariate analysis that PNI on needle biopsy was 
significantly associated to extraprostatic extension 
and seminal vesicle invasion. On multivariate analy-
sis, however, only preoperative PSA, proportion of 
the biopsy involved by cancer, and Gleason score 
were significant. Ukimura et al. (4) found that PNI 
on biopsy was a good predictor among others studied 
for extraprostatic extension on univariate analysis but 
not on multivariate analysis. In the study by Vargas 
et al. (5) PNI was not an independent predictor of 
extraprostatic extension when PSA was included.
 D’Amico et al. (7) evaluated the clinical use 
of PNI on biopsy for predicting time to PSA failure 
following radical prostatectomy of 750 men with 
clinically localized or PSA detected prostate cancer. 
The presence of PNI on biopsy was not a significant 
predictor of PSA outcome following RP for patients 
in the intermediate or high-risk group. O’Malley et al. 
(9) compared 78 biopsies with PNI with 78 matched 
controls without PNI and were unable to show that 
PNI on needle biopsy influences long-term tumor-free 
survival. Freedland et al. (10) studied 190 men who 
underwent radical prostatectomy. Percent of tissue 
with cancer on biopsy was the strongest predictor of 
biochemical recurrence on multivariate analysis. PNI 
was not an independent predictor of either adverse 
pathology or biochemical failure.
 In Bismar’s et al. study (11) neither presence 
nor absence of perineural nor number nor percentage 
of positive nerves were related to pathologic stage on 
univariate or multivariate analyses. In Tsuzuki’s et al. 
study (12) PSA, Gleason score, digital rectal exami-
nation, percent of side specific cores with tumor and 
average percent involvement of each positive core 
but not PNI were found to be statistically significant 
independent predictors of extraprostatic extension in 
the region of the neurovascular bundle. Studying 452 
consecutive patients undergoing radical retropubic 
prostatectomy by a single surgeon, Cannon et al. 
(13) concluded that although biopsy PNI alone was 
associated with a higher probability of extraprostatic 
extension, it was not predictive of bilateral nerve-
sparing technique or a positive surgical margin in an 
individual patient.
 In other studies, however, PNI was an in-
dependent predictor of final pathologic stage. de la 
Taille et al. (3) found that PNI, PSA and Gleason 
score on the biopsy independently predicted stage 
pT3 disease. The authors concluded that PNI is an 
important preoperative predictor of pathologic stage 
and should be reported when adenocarcinoma is di-
agnosed on prostate needle biopsies. In the Sebo et 
al. study (8) joint predictors of extraprostatic exten-
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sion were the percent cores positive for carcinoma, 
Gleason score of 7, Gleason score of 8 or 9, serum 
PSA and PNI. In the Loeb et al. study (15), PNI was 
significantly associated with aggressive pathology and 
biochemical progression. On multivariate analysis, 
PNI was significantly associated with extraprostatic 
extension and seminal vesicle invasion. Bastacky et 
al. (1) studied 302 needle prostatic biopsies and found 
a sensitivity of 27% and a specificity of 96% for PNI 
to predict extraprostatic extension. They concluded 
that measuring PNI on needle biopsy helps identify 
extraprostatic extension and may help in planning 
nerve-sparing radical prostatectomy in the decision 
of whether to sacrifice part or all of the neurovascular 
bundle on the side of the biopsy. These authors did not 
study the predictive value on multivariate analysis.
 Some factors may be responsible for the 
discrepancies in the literature: the number of cores 
examined per case may influence the rate of detection 
of PNI, the different methods of processing and sub-
mitting tissue from radical prostatectomy specimens 
(completely vs. partially embedded prostate glands) 
may contribute to different rates of detection of ex-
traprostatic carcinoma, different definitions of PNI on 
needle biopsy tissue and extraprostatic extension, and 
different values of PSA for evaluation of biochemi-
cal progression-free outcome following surgery. In a 
search from January 1990 to December 2005 using 
MEDLINE, Embase, and the Web of Knowledge, 
Harnden et al. (14) performed a systematic review 
of studies that examined the association between 
perineural invasion and prostate cancer recurrence. 
These authors concluded that a considerable variation 
in study design, execution, and reporting precluded 
meta-analysis and quantitative risk estimation.
 The frequency of perineural invasion on 
needle prostatic biopsies varies from 11% to 38% (1-
6,8,10,11). Considering all biopsies in our study the 
frequency was 18%. In the group with less extensive 
tumors the frequency was 10.6% and in the group with 
more extensive tumors 25.8%. It is worth noting that 
in less extensive tumors the frequency of PNI is in the 
lower range of the frequency found in the literature. 
Studying very small tumors on biopsies (less than 1 
mm in length in only one core), Thorson et al. (23) still 
found a frequency of 2% of PNI. We have also seen 
PNI invasion in autopsied patients with very small 
incidentally found histologic carcinomas. These find-
ings probably suggest that PNI may be an early event. 
This suggestion is shared by Byar and Mostofi (24). 
The authors studied 208 total prostates removed using 
the step-section technique for early carcinoma of the 
prostate. The high frequency of PNI found (84.1%) 
suggested by the authors that the phenomenon occurs 
early in the course of the disease. The similarity in the 
survival rates for cases with and without PNI indicated 
little if any prognostic significance.
 Our study may have some limitations. All 
patients were submitted to radical prostatectomy, and 
therefore we were unable to determine any different 
effect of PNI on biochemical progression-free outcome 
with other forms of treatment, such as watchful waiting 
or radiotherapy. Another limitation could be related to 
the fact that we only recorded the presence or absence 
of PNI on needle biopsy but did not quantify the extent. 
In addition, the mean follow-up is relatively short, and 
it is possible that greater differences could occur with 
additional follow-up. A strength of the study could 
be the homogeneity of the study population which 
was comprised of consecutive patients treated by one 
expert surgeon limiting any influence of variability in 
surgical technique and the pathological evaluation also 
by one senior uropathologist.
 In summary, tumor extent on needle biopsies 
influences the predictive value of PNI for pathologic 
stage > pT2 (pT3a and/or pT3b) on radical prosta-
tectomies. In patients with more extensive tumors 
on needle biopsy, PNI predicted pathologic stage > 
pT2 on radical prostatectomy on univariate analysis 
but on multivariate analysis did not show indepen-
dent predictive value. This finding is in accordance 
to most of the studies reported in the literature. In 
patients with less extensive tumors on biopsy (≤ 
13.6% of tissue in mm containing carcinoma) and 
PNI, there was no association between any clinical 
or pathological variables studied; no difference in the 
time to biochemical (PSA) progression-free outcome 
comparing to patients without PNI; and, no predictive 
value for pathological stage > pT2 on both univariate 
and multivariate analysis. With a higher number of 
small tumors currently detected, there is no evidence 
that perineural invasion should influence the decision 
on preservation of the nerve during radical prostatec-
tomy.
446




1. Bastacky SI, Walsh PC, Epstein JI: Relationship 
between perineural tumor invasion on needle biopsy 
and radical prostatectomy capsular penetration in 
clinical stage B adenocarcinoma of the prostate. Am 
J Surg Pathol. 1993; 17: 336-41.
2. Egan AJ, Bostwick DG: Prediction of extraprostatic 
extension of prostate cancer based on needle biopsy 
findings: perineural invasion lacks significance on 
multivariate analysis. Am J Surg Pathol. 1997; 21: 
1496-500.
3. de la Taille A, Katz A, Bagiella E, Olsson CA, O’Toole 
KM, Rubin MA: Perineural invasion on prostate needle 
biopsy: an independent predictor of final pathologic 
stage. Urology. 1999; 54: 1039-43.
4. Ukimura O, Troncoso P, Ramirez EI, Babaian RJ: Pros-
tate cancer staging: correlation between ultrasound 
determined tumor contact length and pathologically 
confirmed extraprostatic extension. J Urol. 1998; 159: 
1251-9.
5. Vargas SO, Jiroutek M, Welch WR, Nucci MR, 
D’Amico AV, Renshaw AA: Perineural invasion in 
prostate needle biopsy specimens. Correlation with 
extraprostatic extension at resection. Am J Clin Pathol. 
1999; 111: 223-8.
6. Rubin MA, Bassily N, Sanda M, Montie J, Strawder-
man MS, Wojno K: Relationship and significance of 
greatest percentage of tumor and perineural invasion 
on needle biopsy in prostatic adenocarcinoma. Am J 
Surg Pathol. 2000; 24: 183-9.
7. D’Amico AV, Wu Y, Chen MH, Nash M, Renshaw 
AA, Richie JP: Perineural invasion as a predictor of 
biochemical outcome following radical prostatectomy 
for select men with clinically localized prostate cancer. 
J Urol. 2001; 165: 126-9.
8. Sebo TJ, Cheville JC, Riehle DL, Lohse CM, Pan-
kratz VS, Myers RP, et al.: Predicting prostate car-
cinoma volume and stage at radical prostatectomy 
by assessing needle biopsy specimens for percent 
surface area and cores positive for carcinoma, 
perineural invasion, Gleason score, DNA ploidy 
and proliferation, and preoperative serum prostate 
specific antigen: a report of 454 cases. Cancer. 
2001; 91: 2196-204.
9. O’Malley KJ, Pound CR, Walsh PC, Epstein JI, Partin 
AW: Influence of biopsy perineural invasion on long-
term biochemical disease-free survival after radical 
prostatectomy. Urology. 2002; 59: 85-90.
10. Freedland SJ, Csathy GS, Dorey F, Aronson WJ: 
Percent prostate needle biopsy tissue with cancer is 
more predictive of biochemical failure or adverse 
pathology after radical prostatectomy than prostate 
specific antigen or Gleason score. J Urol. 2002; 167: 
516-20.
11. Bismar TA, Lewis JS Jr, Vollmer RT, Humphrey PA: 
Multiple measures of carcinoma extent versus perineu-
ral invasion in prostate needle biopsy tissue in predic-
tion of pathologic stage in a screening population. Am 
J Surg Pathol. 2003; 27: 432-40.
12. Tsuzuki T, Hernandez DJ, Aydin H, Trock B, Walsh 
PC, Epstein JI: Prediction of extraprostatic extension 
in the neurovascular bundle based on prostate needle 
biopsy pathology, serum prostate specific antigen and 
digital rectal examination. J Urol. 2005; 173: 450-3.
13. Cannon GM Jr, Pound CR, Landsittel DP, Bastacky 
SI, Dhir R, Becich MJ, et al.: Perineural invasion in 
prostate cancer biopsies is not associated with higher 
rates of positive surgical margins. Prostate. 2005; 63: 
336-40.
14. Harnden P, Shelley MD, Clements H, Coles B, Tyn-
dale-Biscoe RS, Naylor B, et al.: The prognostic 
significance of perineural invasion in prostatic cancer 
biopsies: a systematic review. Cancer. 2007; 109: 13-
24.
15. Loeb S, Epstein JI, Humphreys EB, Walsh PC: Does 
perineural invasion on prostate biopsy predict adverse 
prostatectomy outcomes? BJU Int. 2009; 19. [Epub 
ahead of print]
16. Bostwick DG, Montironi R: Evaluating radical pros-
tatectomy specimens: therapeutic and prognostic 
importance. Virchows Arch. 1997; 430: 1-16.
17. Epstein JI, Carmichael M, Walsh PC: Adenocarcinoma 
of the prostate invading the seminal vesicle: definition 
and relation of tumor volume, grade and margins of 
resection to prognosis. J Urol. 1993; 149: 1040-5.
18. Billis A, Freitas LL, Magna LA, Samara AB, Ferreira 
U: Prostate cancer with bladder neck involvement: 
pathologic findings with application of a new practical 
method for tumor extent evaluation and recurrence-
free survival after radical prostatectomy. Int Urol 
Nephrol. 2004; 36: 363-8.
19. Billis A, Magna LA, Ferreira U: Correlation between 
tumor extent in radical prostatectomies and preopera-
tive PSA, histological grade, surgical margins, and 
extraprostatic extension: application of a new practical 
447
Perineural Invasion on Needle Prostatic Biopsies
method for tumor extent evaluation. Int Braz J Urol. 
2003; 29: 113-9; discussion 120.
20. Gleason DF, Mellinger GT: Prediction of prognosis for 
prostatic adenocarcinoma by combined histological 
grading and clinical staging. J Urol. 1974; 111: 58-
64.
21. Gleason DF: Histologic grading and clinical staging of 
prostatic carcinoma. In: Tannenbaum M (ed.), Urologic 
pathology: The prostate. Philadelphia, Lea & Febiger. 
1977; pp. 171-98.
22. Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, 
D’Amico AV, Dmochowski RR, et al.: Variation in the 
definition of biochemical recurrence in patients treated 
for localized prostate cancer: the American Urological 
Association Prostate Guidelines for Localized Prostate 
Cancer Update Panel report and recommendations for a 
standard in the reporting of surgical outcomes. J Urol. 
2007; 177: 540-5.
23. Thorson P, Vollmer RT, Arcangeli C, Keetch DW, 
Humphrey PA: Minimal carcinoma in prostate needle 
biopsy specimens: diagnostic features and radical pros-
tatectomy follow-up. Mod Pathol. 1998; 11: 543-51.
24. Byar DP, Mostofi FK: Carcinoma of the prostate: prog-
nostic evaluation of certain pathologic features in 208 
radical prostatectomies. Examined by the step-section 
technique. Cancer. 1972; 30: 5-13.




Anatomia Patológica, FCM, Unicamp
Caixa Postal 6111
Campinas, SP, 13084-971, Brazil
E-mail: athanase@fcm.unicamp.br
448
Perineural Invasion on Needle Prostatic Biopsies
EDITORIAL COMMENT
 The importance of perineural invasion (PNI) 
in prostate biopsies remains controversial in the 
literature. The studies published since 1993 have 
shown an incidence of PNI variable from 11% to 38% 
significantly related to unfavorable histological fea-
tures, specially extra-prostatic extension (EPE) and 
positive surgical margins (1,2). Some authors have 
shown a relationship between PNI and biochemical 
recurrence, and because of that, the description of 
the presence or absence of PNI in prostate biopsies 
plays a role in surgical pathology reports. The authors 
studied 264 patients, finding 18.2% of PNI related 
to EPE, higher Gleason score and seminal vesicles 
(SV) infiltration only for extensive tumors. How-
ever, they did not find any correlation between PNI 
and tumor progression. The most robust study was 
published recently by Loeb et al. (3) describing the 
Johns Hopkins experience with 1256 men submitted 
to radical prostatectomy, and they found a correlation 
between PNI with EPE and SV infiltration in mul-
tivariate analysis. In addition to the fact that tumor 
progression occurred in 10.5% of patients with PNI 
and in only 3.5% of patients without PNI, this aspect 
was not an independent risk factor for biochemical 
recurrence. Most importantly, it was not considered 
to decide nerve-sparing surgery. Since there is some 
agreement that PNI is related to aggressive pathologic 
features, we believe it is important that pathologists 
continue to describe the presence or absence of PNI 
to give the opportunity to surgeons, oncologists and 
radiotherapists to take this aspect in account to better 
plan patients’ treatment.
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EDITORIAL COMMENT
 The authors are to be commended on this 
thorough analysis of how transrectal prostate needle 
biopsy specimens correlate with whole mount pros-
tatectomy specimens. This study is solid based on 
the large number of patients (264). There is further 
strength in that a single surgeon performed each radi-
cal retropubic prostatectomy, while all of the pathol-
ogy was interpreted by a single pathologist. Finally, 
the statistical methods employed were appropriate for 
this type of analysis.
 In the literature, there is great controversy 
regarding the significance of perineural invasion 
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(PNI). There are as many reports to suggest signifi-
cance of PNI as there are reports that demonstrate no 
difference in patient outcomes. Specifically, can PNI 
predict preoperatively the presence of extracapsular 
extension (ECE) at the time of radical prostatectomy? 
Naturally, if this can be shown that a patient is at risk 
preoperatively for ECE, the surgeon may electively 
alter the technique to sacrifice part or all of the neu-
rovascular bundle on the ipsilateral side of the dis-
ease. Additionally, this information may be useful in 
counseling patients pre-treatment regarding the pros 
and cons of various treatment options.
 This report by Billis et al., does in fact demon-
strate a subset of patients that have a significant risk of 
having a higher grade Gleason score, ECE and seminal 
vesicle involvement at the time of radical prostatec-
tomy. Specifically, it was the group of patients in that 
more than 13.6% of linear (mm) malignant involve-
ment was identified in the needle biopsy specimens. 
25.8% of this cohort possessed PNI. Fortunately, 
regarding overall freedom from biochemical pro-
gression, there was no significant difference between 
those with and without PNI. Without question, better 
pretreatment patient selection will ultimately improve 
treatment outcomes. It is not uncommon to assume 
a patient has low risk criteria when in fact, they may 
harbor more advanced disease. In the future, clinicians 
will utilize more sophisticated biopsy techniques and 
apply known pathologic risk factors to decrease the 
risk of understaging prostate cancer.
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